Medtronic (NYSE: MDT) announced today that it appointed Dr. Adam S. Arthur as chief medical officer for its Neurovascular ...

Medtronic (MDT) is undervalued, with strong organic growth and an 11% upside to a $105 target price, supporting a Buy rating.

Opinion: The Eighth Circuit's decision in a dispute over how Medtronic priced its intercompany licenses shows that the crux ...

Medtronic (NYSE:MDT) announced on Tuesday that the U.S. FDA cleared its SmartGuard algorithm as an interoperable automated glycemic controller, allowing the integration of its MiniMed 780G insulin ...

Brett Wall has overseen the neuroscience portfolio of Medtronic, one of the world’s largest medical device makers valued at ...

On September 2, 2025, Medtronic plc (NYSE:MDT) announced that the FDA cleared its SmartGuard algorithm as an interoperable automated glycemic controller, allowing its integration with Abbott’s ...

The FDA has approved Medtronic’s MiniMed 780G automated insulin delivery (AID) system for use in type 2 diabetes (T2D). At the same time, FDA also cleared the MiniMed SmartGuard algorithm as an ...

Medtronic PLC, a global leader in medical technology with a market capitalization of $119 billion, has been navigating a complex landscape of innovation, strategic initiatives, and market challenges.

Business: Medtronic PLC is an Ireland-based company, which provides health-care technology solutions. The company's products category includes Advanced Surgical Technology; Cardiac Rhythm; ...

NORTH HAVEN — A maintenance supervisor at a medical manufacturing company started searching for other work after bosses questioned his purchases on a company credit card totaling more than ...

Since 1993, I have offered an annual list of 10 stocks with the potential to beat the market in the 12 months ahead. My 2024 selections notched the highest return ever: an average of 48.9%. I beat the ...